Let me know what you think

UnitedHealth
Price
Discussão sobre UNH
Postos
334🚀 $UNH was the most bought stock by hedge funds! 📈
No segundo trimestre a UnitedHealth Group ($UNH (+3,46%) ) foi a ação mais comprada pelos hedge funds!
Insiders, reguladores, hedge funds, etc, aparentemente estão todos a comprar.📊
No entanto a ação continua em mínimos, tendo corrigido 57% em 1 ano. Será que estamos perante uma oportunidade?
$UNH
$UNH
$TSM (+0,36%)
$GOOGL (-0,48%)
$META (-0,61%)
$TMO (+0,88%)
$TXN (-0,95%)
$AMAT (+0,85%)
$ICON
$ADBE (+0,68%)
$BAC (+0%)
$WBD (+6,9%)
$AVGO (-0,33%)
$MCHP (+0,65%)

Some hedge funds pursue a "market neutral" strategy or simply close short positions🤷🏽♂️
My vision for the depot of the future 👀
A portfolio that supports long-term, solid growth and remains balanced. The focus is on global diversification, strong dividend payers, stable industry leaders and a targeted admixture of future-oriented stocks, including in the crypto sector.
✅ = already available
👀 = on the watchlist, interesting in terms of price soon
❌ = not yet interesting in terms of price at present
ETF selection
- FTSE All World ✅ = Global basis, broadly diversified. $VWRL (+0,17%)
MSCI World Tech ✅ = Focus on innovative technology stocks.- Defense USD 👀 = Stability through defense and security.
- FTSE High Dividend 👀 = Dividend-oriented addition.
Single stock focus
Energy & commodities:
Shell ✅, Chevron 👀, Exxon 👀, Rio Tinto ❌ $SHEL (+0,53%)
$CVX (+0,41%)
$XOM (+0,21%)
$RIO (+1,06%)
Insurers & reinsurers:
Munich Re ✅, Hannover Re ✅, Swiss Re ❌, Allianz ❌, Swiss Life AG ❌ $ALV (+1,33%)
$SREN (+0,35%)
$SLHN (+0,39%)
$HNR1 (-0,16%)
$MUV2 (+0,68%)
Finance & payment transactions:
Brown & Brown ✅, Marsh & McLennan ✅, Visa ✅, Mastercard ❌, PayPal 👀 $PYPL (+2,09%)
$BRO (+0,09%)
$MMC (-0,04%)
$V (+1,44%)
$MA (+0,87%)
Technology & data:
Alphabet 👀, NVIDIA ❌ , Palantir ❌,
Amazon 👀, Apple ❌, Microsoft ❌, Baidu 👀 $9888 (+3,29%)
$AAPL (+0,51%)
$GOOGL (-0,48%)
$PLTR (+0,03%)
$NVDA (-0,69%)
Health & consumption:
Novo Nordisk 👀, Zoetis 👀, Coca-Cola ❌, Walmart 👀, United Health 👀 $UNH (+3,46%)
$NOVO B (+1,15%)
$ZTS (+0,83%)
$KO (-0,41%)
$WMT (-1,62%)
Automotive & Mobility:
BMW ❌, Mercedes 👀, Tesla ❌ $TSLA (+1,15%)
$BMW (+1%)
$MBG (+0,53%)
Cryptos
- XRP ✅ $XRP (+0,18%)
RENDER ✅ $RENDER (+2,83%)
Bitcoin (BTC) ❌ $BTC (+1,1%)
Solana (SOL) 👀 $SOL (+5,15%)
Ethereum (ETH) ❌ $ETH (+2,11%)
For the weekend
Strategy remains: Patience, discipline and an eye for opportunities.
📈🌾
PS: You still need a cool name for the portfolio.
So now also
I have 50 shares of $NOVO B (+1,15%) at a price of €66. I still believe that it is not wrong to be positioned with Novo and $UNH (+3,46%) (10 shares at €353), but perhaps one should not overdo it. The positions are large enough to have a noticeable effect on a full recovery, but I don't need to overload myself to create an even bigger buy-in.
Basically, there is much to suggest that the market is simply acting excessively panicky and headless and that the healthcare sector itself is not in demand (see post before last). Especially when Trump is throwing out some TACOs saying that he wants to regulate pharmaceutical prices - and although pharma is taking a dive, health insurers are still not benefiting from this. A lot of things on the market don't fit together at the moment.
Sometimes I'm also right. Sometimes. I have $SHOP (+0,09%) at €30 and $NVDA (-0,69%) for €12 when nobody wanted the shares, but the trick is of course that you always have too many shares in stocks that fall and too few in stocks that rise. You can sometimes make the perfect start with a single tranche, but you will rarely take €100,000 in the morning after a good night's sleep and find the golden turnaround with a single purchase ... so just in case anyone gets the idea that you can simply get in later when the shares are rising again: you won't do that anyway.
My share price targets for Q4 2025 🔮
$NOVO B (+1,15%) 29,50€
$UNH (+3,46%) 230€
$TSLA (+1,15%) 400€
$MSFT (-0,04%) 385€
$PLTR (+0,03%) 69€
$HIMS (-0,9%) 35€
$NVDA (-0,69%) 130€
$DRO (+1,61%) 1,49€
$RHM (+0,73%) 1750€
$LMND (+8,37%) 24€
$OSCR 9,89€
$MUV2 (+0,68%) 599€
$ASML (+1,34%) 549€
$MC (+1,79%) 401€
OPEX continues to fall 🚀
One of the most impressive key figures when you have growth of 80 % (800,000 customers)
while operating costs continue to fall.
This shows very nicely how AI and automation can have an impact on a company/business model that has been built and trained from the ground up with artificial intelligence.
There are hardly any other companies where the number of employees remains almost the same or the number of employees is likely to have decreased between 2022 and 2025, but the company continues to grow strongly.
Employees 2022: approx. 1367
Employees 2025 approx. 1235
(According to my internet research)
$PGR (+1,65%)
$BRO (+0,09%)
$ALV (+1,33%)
$MUV2 (+0,68%)
$ALL (+0,93%)
$UNH (+3,46%)
$HNR1 (-0,16%)
$BRK.B (+1,45%)
$ZURN (+1,01%)
$CS (+1,44%)


Lemonade Q2'25 result highlights 🚀👌
- Revenue: $164.1M (Est. $161.4M) ✅; UP +46% YoY
- EPS: -$0.60 (Est. -$0.80) ✅
- In-Force Premium: $840M; UP +22% YoY
Customer & Premium Metrics
- Premium per Customer: $394; UP +11% YoY
- Total Customers: 2.1M; UP +10% YoY
- Policies in Force: 2.13M
- Annual Dollar Retention (ADR): 87%
Other Q2 Metrics:
- Gross Profit: $41.3M; UP +91% YoY
- Adj EBITDA: -$30.4M
- Net Loss: $41.6M
- Gross Loss Ratio: 77% (vs. 94% YoY)
- Cash & Investments: $888M
- Net Cash Used in Operating Activities: -$29.8M
CEO comment:
🟡 "We achieved record sales and margin improvements. This is the strongest second quarter in Lemonade's history."
🟡 "We are on track to achieve our target of adjusted EBITDA profitability by mid-2026."
$BRO (+0,09%)
$BRK.B (+1,45%)
$BRK.A (+1,45%)
$PGR (+1,65%)
$ALV (+1,33%)
$MUV2 (+0,68%)
$CS (+1,44%)
$HNR1 (-0,16%)
$UNH (+3,46%)
$ALL (+0,93%)
$601318
$CB (+1,3%)
$ZURN (+1,01%)
$TLX (+0,34%)
$HSX (-1,29%)


Purchase United Health
$UNH (+3,46%) 2.tranche buy swim against the tide 💪
First Hims sale to take out risk! 💪
After$HIMS (-0,9%) recently published mediocre figures and the share accounted for over 60% of my portfolio, I took advantage of the market strength in early trading today. At a price of €50.40, I reduced my position by 60% to secure profits.
Although I still hold 1000 shares and believe in the company for the long term, it is sensible to cash out after a gain of over 600% in just three years. This also gives me the opportunity to invest in other promising stocks on my watchlist.
The remaining position will remain an important part of my portfolio for a long time to come, as I still consider $HIMS (-0,9%) still see it as one of my best long-term investments.
Yes, the tax is extremely painful, but with this decision I can now sleep more relaxed again.
What stocks are you currently looking at and where would you currently invest your money? And no $NOVO B (+1,15%) or $UNH (+3,46%) does not come into my house 🤣
Greetings, Bubu

But congratulations on your return 👍🏻💥🗡️
Lemonade Q2'25 result highlights 🚀👌
- Revenue: $164.1M (Est. $161.4M) ✅; UP +46% YoY
- EPS: -$0.60 (Est. -$0.80) ✅
- In-Force Premium: $840M; UP +22% YoY
Customer & Premium Metrics
- Premium per Customer: $394; UP +11% YoY
- Total Customers: 2.1M; UP +10% YoY
- Policies in Force: 2.13M
- Annual Dollar Retention (ADR): 87%
Other Q2 Metrics:
- Gross Profit: $41.3M; UP +91% YoY
- Adj EBITDA: -$30.4M
- Net Loss: $41.6M
- Gross Loss Ratio: 77% (vs. 94% YoY)
- Cash & Investments: $888M
- Net Cash Used in Operating Activities: -$29.8M
CEO comment:
🟡 "We achieved record sales and margin improvements. This is the strongest second quarter in Lemonade's history."
🟡 "We are on track to achieve our target of adjusted EBITDA profitability by mid-2026."
$BRO (+0,09%)
$BRK.B (+1,45%)
$BRK.A (+1,45%)
$PGR (+1,65%)
$ALV (+1,33%)
$MUV2 (+0,68%)
$CS (+1,44%)
$HNR1 (-0,16%)
$UNH (+3,46%)
$ALL (+0,93%)
$601318
$CB (+1,3%)
$ZURN (+1,01%)
$TLX (+0,34%)
$HSX (-1,29%)


Títulos em alta
Principais criadores desta semana